JB Chemicals Pharmaceuticals - Concurrent Gainers 9 stocks that gain for 5 days in a row - The Economic Times
| JBCHEPHARM | 1,746 24.00 1.39% |
Under 51% of JB Chemicals' traders are presently thinking to get in. The analysis of overall sentiment of trading JB Chemicals Pharmaceuticals stock suggests that some investors are interested at this time. JB Chemicals' investing sentiment shows overall attitude of investors towards JB Chemicals Pharmaceuticals.
JBCHEPHARM |
JB Chemicals Pharmaceuticals - Concurrent Gainers 9 stocks that gain for 5 days in a row The Economic Times
Read at news.google.com
 |
JB Chemicals Fundamental Analysis
We analyze JB Chemicals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of JB Chemicals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of JB Chemicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
JB Chemicals is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
JB Chemicals Pharmac Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with JB Chemicals stock to make a market-neutral strategy. Peer analysis of JB Chemicals could also be used in its relative valuation, which is a method of valuing JB Chemicals by comparing valuation metrics with similar companies.
Peers
JB Chemicals Related Equities
| PARAGMILK | Parag Milk | 2.83 | ||||
| KINGFA | Kingfa Science | 2.23 | ||||
| HEUBACHIND | Heubach Colorants | 0.45 | ||||
| TBZ | Tribhovandas Bhimji | 0.83 | ||||
| HEMIPROP | Hemisphere Properties | 1.01 | ||||
| RICOAUTO | Rico Auto | 1.87 | ||||
| GATECHDVR | GACM Technologies | 2.11 | ||||
| DELTAMAGNT | Delta Manufacturing | 3.08 | ||||
| COSMOFIRST | COSMO FIRST | 3.15 | ||||
| GANGOTRI | Gangotri Textiles | 5.22 |
Complementary Tools for JBCHEPHARM Stock analysis
When running JB Chemicals' price analysis, check to measure JB Chemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JB Chemicals is operating at the current time. Most of JB Chemicals' value examination focuses on studying past and present price action to predict the probability of JB Chemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move JB Chemicals' price. Additionally, you may evaluate how the addition of JB Chemicals to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |